B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Larotrectinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Larotrectinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

gw632580x
3 shared targets
bdb
3 shared targets
selitrectinib
3 shared targets
repotrectinib
3 shared targets
lorlatinib
4 shared targets
purvalanol
2 shared targets
entrectinib
4 shared targets
sns
2 shared targets
tryptanthrin
2 shared targets
bms
2 shared targets
Loading evidence profile...

This evidence profile for Larotrectinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.